Volume 7, Number 2, Supplement 1 (March/April 2009)

Highlights from the
Fourth Annual Chicago Supportive Oncology Conference

This supplement is a continuing education activity jointly sponsored by the Meniscus Education Institute and The Journal of Supportive Oncology.

Information About This Continuing Education Activity
Intended Audience • Learning Objectives • Rationale and Purpose • Continuing Education • Financial Disclosures • Education Committee and Pilot Study Reviewers • Faculty • Disclaimer

full text 139 kb
Release date: March 31, 2009 • CE available until: September 30, 2010

Contents

6

  

Metastatic Bone Disease: Zoledronic Acid and Beyond
James R. Berenson, MD

7

  

Maintaining Bone Health in Patients with Cancer
Charles Shapiro, MD

8

  

Osteonecrosis of the Jaw: Significant But Rare Complication of Bisphosphonates
Ellen Eisenberg, DMD

10

  

Improving Functional Outcomes in Head and Neck Cancer
Jan S. Lewin, PhD

11

  

Continuity of Rehabilitative Care for Head and Neck Cancer Survivors
Ann Marie Flores, PhD, PT

13

  

Cancer Treatment: The Oral Health Connection
Joel B. Epstein, DMD, MSD

14

  

Voices from the Lived World of Illness
Lidia Schapira, MD

15

  

Musculoskeletal Symptoms and Aromatase Inhibitors
Harold J. Burstein, MD, PhD

16

  

Intraperitoneal Therapy for Ovarian Cancer: Controlling the Toxicity
David R. Spriggs, MD

17

  

Minimizing Toxicity to Interferon: A Key to Completing Treatment
David H. Lawson, MD

19

  

Depression and Cancer: A Common Biology
Charles Raison, MD

20

  

Grief During the Course of Illness
Michael J. Fisch, MD, MPH

21

  

Cardiotoxicity in Breast Cancer Patients
Daniel J. Lenihan, MD

22

  

Cognitive Impairment Associated with Breast Cancer Therapy
Paul Jacobsen, PhD

23

  

Sexuality Issues and Testosterone Replacement in Women with Breast Cancer
Debra L. Barton, RN, PhD, AOCN

25

  

A Systems Approach to Improving Pain Control
Barbara A. Murphy, MD

26

  

Opioids and Adjuvant Analgesics for Neuropathic Pain
Judith A. Paice, RN, PhD

28

  

Beyond Pain: New Directions in Cancer Symptom Research
Charles S. Cleeland, PhD

30

  

Integrating Supportive and Palliative Care into Oncology
Lawrence H. Einhorn, MD

31

  

NCI-Sponsored Research in Symptom Management
Lori Manasian, MD

33

  

Graft-Versus-Host Disease: Reversing the Burden of Symptoms
Madan Jagasia, MD

34

  

Chronic Graft-Versus-Host Disease: Supportive Care Critical to Well-Being
Stephanie J. Lee, MD, MPH

35

  

New Directions for Antiemetic Therapies
Mark G. Kris, MD

37

  

Dermatotoxicity Linked to Targeted Biologic Agents
Mona Gandhi, MD

38

  

Malignant Spinal Cord Compression: Improving Outcomes
Andrew Loblaw, MD

40

  

Dyspnea: Underrecognized and Undertreated
Deborah Dudgeon, MD

41

  

Palliative Care: Changing the Culture of Medicine
Charles F. von Gunten, MD, PhD

42

  

Managing Constipation in Cancer Patients
Jay R. Thomas, MD, PhD

43

  

Managing Mucositis Due to Chemotherapy
Nathaniel S. Treister, DMD, DMSc

44

  

Cachexia and the Role of Cytokines
Egidio Del Fabbro MD

full text 428 kb

Continuing Education

46

  

Learning Assessment and Evaluation Form
To receive continuing education credit, you must read this publication, score at least 70% on the learning assessment, and submit the evaluation form by September 30, 2010, via fax, mail, or the Internet to the Meniscus Educational Institute. Download the form for further information.

learning assessment 58 kb evaluation form 189 kb

 

Online Registration and Evaluation
To register and complete the post test and evaluation form online, click the button below. There is no fee for this educational activity.

online evaluation

Supported by educational grants from Eisai Inc., EKR Therapeutics, and Endo Pharmaceuticals

© 2009 Elsevier Inc. All rights reserved. No part of this publication may be reproduced or transmitted in any form or by any means, electronic or mechanical, including photocopy, recording, or any information storage and retrieval system, without written permission from the publisher.

The opinions expressed herein are those of the authors or advertisers. The authors, editors, and publishers make every effort to ensure that no inaccurate or misleading data, opinion, or statement is published in this journal and that drug names, dosages, and recommendations are accurate. However, readers should confirm all dosage schedules against the manufacturer’s package information data. The Publisher, Editorial Board, and their employees accept no liability whatsoever for the consequences of any inaccurate or misleading data, opinion, or statement.